trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Glimepiride is an effective treatment for type 1 diabetes mellitus.

the verdict
REFUTED
the evidence says no
Recorded sources
0 sources for · 4 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Glimepiride is an effective treatment for type 1 diabetes mellitus?

No. Glimepiride is a sulfonylurea medication indicated for the management of type 2 diabetes mellitus, whereas type 1 diabetes mellitus is characterized by absolute insulin deficiency and requires insulin therapy. Therefore, glimepiride is not an effective or appropriate treatment for type 1 diabetes.

Verdict: REFUTED · 0 sources for, 4 against · Last checked

The analysis

The claim states that glimepiride is an effective treatment for type 1 diabetes mellitus. All retrieved papers concerning glimepiride evaluate its use strictly in the context of type 2 diabetes mellitus, as sulfonylureas require functional pancreatic beta cells which are destroyed in type 1 diabetes. The evidence and established medical consensus directly refute the claim.

Evidence against · 4
Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical Study.
2026
Demonstrates the use of glimepiride in patients with type 2 diabetes mellitus.
Get citation
R, S., A, G., MK, S., AG, R., R, D., D, G., J, S., V, A., SS, P., A, C., SB, K. N., A, P., SK, G., AK, S., PK, R., R, S., S, S., D, P., P, G., P, P., L, L., S, M., & S, J. (2026). Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical Study.. doi.org. https://doi.org/10.1111/dom.70778

See more details
More against · 3
Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
2013
Investigates the efficacy and safety of glimepiride specifically for type 2 diabetes mellitus.
Get citation
Ametov, A. S. & Abaeva, F. T. (2013). Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus. doi.org. https://doi.org/10.14341/dm2013495-100

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
2010
Concludes that glimepiride is an efficacious agent for the treatment of type 2 diabetes.
Get citation
Romantsova, T. I. & Maksimova, N. V. (2010). Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride. doi.org. https://doi.org/10.14341/2072-0351-6017

Repositioning Tradition: A Narrative Review and Expert Opinion on the Clinical Positioning of Glimepiride and Metformin in Nepal's Type 2 Diabetes Mellitus (T2DM) Landscape.
2026
Discusses the clinical positioning of glimepiride and metformin for type 2 diabetes mellitus.
Get citation
S, C., M, P., S, S., D, M., KK, A., S, K., T, K., & A, M. (2026). Repositioning Tradition: A Narrative Review and Expert Opinion on the Clinical Positioning of Glimepiride and Metformin in Nepal's Type 2 Diabetes Mellitus (T2DM) Landscape.. doi.org. https://doi.org/10.7759/cureus.110712

What does the evidence say?

The claim states that glimepiride is an effective treatment for type 1 diabetes mellitus. All retrieved papers concerning glimepiride evaluate its use strictly in the context of type 2 diabetes mellitus, as sulfonylureas require functional pancreatic beta cells which are destroyed in type 1 diabetes. The evidence and established medical consensus directly refute the claim.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work